Jan 30, 2020 | All News, Awareness and Information
Ethan Holliman was diagnosed with MEN2B at the age of 12 by which time the medullary thyroid cancer (MTC) that is a part of the syndrome had already spread beyond his thyroid gland. MEN2B is best diagnosed within the first year of life, at which time there is a...
Jan 28, 2020 | All News, Awareness and Information
The NET Patient Foundation is delighted to announce that it is rebranding and will soon be known as ‘Neuroendocrine Cancer UK’. This change is to better reflect its community, building on the foundation that has been laid down over the last 17 years (2002 –...
Jan 28, 2020 | All News, Awareness and Information
The Carcinoid Cancer Foundation hosted a special Facebook Live Event on January 23, featuring neuroendocrine tumor (NET) expert Dr. Jonathan Strosberg for an in-depth discussion about Peptide Receptor Radionuclide Therapy (PRRT). Participants were able to submit...
Jan 20, 2020 | All News, Research and Clinical Trials
CNETS Canada was formed in 2007 to assist the Canadian community with this type of disease. Today, CNETS Canada is widely recognized by patients and the medical community across Canada, as an organization that helps improve the quality of life and survival for NET...
Jan 17, 2020 | All News, Research and Clinical Trials
NETRF gave an Accelerator Award to Hans Clevers, MD, PhD, Hubrecht Institute, Netherlands, to develop NET organoids to expand the field’s preclinical NET research tools in 2017. An organoid is a laboratory replica of tumor cells that researchers can study to...
Jan 9, 2020 | All News, Awareness and Information
For the first time, four Patient Ambassadors from the NET Patient Foundation (five if you include Taska, a beautiful Canine Partner Assistance Dog) attended the UKINETs medical conference in the UK. Bethann, Craig, Kath and Sally were in attendance to share heartfelt...
